Analysts raised targets across financials and healthcare on Tuesday, with Goldman Sachs seeing the sharpest jump. The average consensus target for GS rose to $1,085 from $1,037. That is a near-$50 increase. Goldman stock carries a market cap of $350 billion. Short interest sits at just 2.1% of free float.
Eli Lilly also drew fresh upgrades. Its average target climbed to $1,270. The pharma giant crossed $1 trillion in market cap. Analysts remain overwhelmingly bullish — 22 buys, five holds, and just one sell in the consensus.
UnitedHealth Group targets edged up to $438 from $436. The insurer has faced heavy scrutiny in 2026. The target increase signals some renewed confidence. Consensus counts 22 buys and only one sell.
Two names bucked the trend. Microsoft saw a minor target trim, down to $559 from $560. CME Group also slipped, with targets cut to $284 from $285.
PNC Financial rounded out the financials story. Its target rose to $270. Progressive was the only insurer to see a target dip, down to $234.
Overall, the session leaned bullish. Financial and healthcare names drove most of the upward revisions.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
